Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 20 of Estrella Immunopharma, Inc.'s SEC filings and found 3 warrant series, 2 convertibles, 1 equity line, 1 shelf registration, 2 S-1 registrations and 2 completed offerings on file for ESLA. The latest dilution event on file is a registration statement on Jan 23, 2026. Analysis updated Oct 7, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
JSPRJasper Therapeutics, Inc.
PLURPluri Inc. Common Stock
ABOSAcumen Pharmaceuticals, Inc.
ATYRaTyr Pharma, Inc.
HEPAHepion Pharmaceuticals, Inc.
BOLTBolt Biotherapeutics, Inc.
NEUPNeuphoria Therapeutics Inc.
KYNBKyntra Bio, Inc.
QNTMQuantum BioPharma Ltd.
ALLRAllarity Therapeutics, Inc.
MCRBSeres Therapeutics, Inc.
AEONAEON Biopharma, Inc.
RADXRadiopharm Theranostics Limited American Depositary Shares
MRKRMarker Therapeutics, Inc.
CNTXContext Therapeutics Inc.